Bilimsel çalışmalar

Prof. Dr. Ömer Yiğiner

80 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. 1.The Effects of Female Sex Hormones on Ventricular Premature Beats and Repolarization Parameters in Physiological Menstrual Cycle. Dogan M, Yiginer O, Uz O, Kucuk U, Degirmencioglu G, Isilak Z, Uzun M, Davulcu E.Pacing Clin Electrophysiol. 2016 Feb 4. doi: 10.1111/pace.12821. [Epub ahead of print]

    Kaynak: medicana.com.tr profil sayfası

  2. 2.The importance of visceral adipose tissue as a scale for assessing the metabolic syndrome and obesity. Ozcelik F, Yiginer O, Dogan M, Tokatli A. Eur Rev Med Pharmacol Sci. 2016 Jun;20(12):2475

    Kaynak: medicana.com.tr profil sayfası

  3. 3.The use of endogenous substances in the evaluation of renal function in various clinical situations. Ozcelik F, Yiginer O. Eur J Gastroenterol Hepatol. 2016 May;28(5):606. doi: 10.1097/MEG.0000000000000577

    Kaynak: medicana.com.tr profil sayfası

  4. 4.Transmural dispersion of repolarization: a complementary index for cardiac inhomogeneity. Dogan M, Yiginer O, Degirmencioglu G, Un H. J Geriatr Cardiol. 2016 Jan;13(1):99-100. doi: 10.11909/j.issn.1671-5411.2016.01.012

    Kaynak: medicana.com.tr profil sayfası

  5. 5.The Relationship Between Serum Uric Acid Levels and The Major Risk Factors for The Development of Non-Alcoholic Fatty Liver Disease.Ozcelik F, Yiginer O.Liver Int. 2016 Jan 20.

    Kaynak: medicana.com.tr profil sayfası

  6. 6.Relationship between thrombocytopenia and extrahepatic metastasis of hepatocellular carcinoma: a different perspective.Ozcelik F, Yiginer O, Özgün A.Liver Int. 2016 Jan 20

    Kaynak: medicana.com.tr profil sayfası

  7. 7.Paroxysmal atrial fibrillation and related thromboembolism may be a hidden factor in the development of dementia.Tokatli A, Yiginer O, Ozmen N, Uzun M, Kilicaslan F. Psychogeriatrics. 2016 Jan 18. doi: 10.1111/psyg.12186. [Epub ahead of print] No abstract available.

    Kaynak: medicana.com.tr profil sayfası

  8. 8.Heart rate correction should be kept in mind during measurements of ventricular repolarization parameters.Dogan M, Yiginer O, Un H, Dagasan I.Acta Anaesthesiol Belg. 2015;66(3):101.

    Kaynak: medicana.com.tr profil sayfası

  9. 9.Quantitative assessment of cardiac electrical heterogeneity in patients with polycystic ovary syndrome by transmural dispersion of repolarization and atrial electromechanical coupling. Tokatli A, Yiginer O.Eur Rev Med Pharmacol Sci. 2015 Dec;19(24):4688. No abstract available.

    Kaynak: medicana.com.tr profil sayfası

  10. 10.Independently from mitral regurgitation, Barlow disease may cause left ventricular enlargement and thereby anticipation of surgery.Yiginer O, Tokatli A, Dogan M, Ozmen N. Ital J Anat Embryol. 2015;120(1):1-2. No abstract available.

    Kaynak: medicana.com.tr profil sayfası

  11. 11.Prolonged Tp-e Interval, Tp-e/QT Ratio and Tp-e/QTc Ratio in Patients with Type 2 Diabetes Mellitus.Tokatli A, Kiliçaslan F, Alis M, Yiginer O, Uzun M.Endocrinol Metab (Seoul). 2015 Dec 9. [Epub ahead of print]

    Kaynak: medicana.com.tr profil sayfası

  12. 12.Altered atrial conduction in postoperative atrial fibrillation.Tokatli A, Yiginer O.Int J Cardiol. 2016 Jan 15;203:945-6.

    Kaynak: medicana.com.tr profil sayfası

  13. 13.Atrial electromechanical coupling parameters should be kept in mind during the assessment of atrial arrhythmia risk.Yiginer O, Tokatli A, Gokhan D, Dogan M.Eur Rev Med Pharmacol Sci. 2015 Nov;19(21):3989-90. No abstract available.

    Kaynak: medicana.com.tr profil sayfası

  14. 14.Effect of oxidative stress on ventricular repolarization in patients with type 2 diabetes: non-invasive quantification via transmural dispersion of repolarization.Tokatli A, Yiginer O, Kilicaslan F.Endocrine. 2015 Nov 9. [Epub ahead of print] No abstract available.

    Kaynak: medicana.com.tr profil sayfası

  15. 15.Atrial fibrillation may be a hidden factor for the development of cognitive impairment in patients with heart failure.Yiginer O, Tokatli A, Dogan M, Erdal E.J Geriatr Cardiol. 2015 Sep;12(5):590. doi: 10.11909/j.issn.1671-5411.2015.05.007. No abstract available.

    Kaynak: medicana.com.tr profil sayfası

  16. 16.Transmural dispersion of repolarization and atrial electromechanical coupling: complementary indices for quantifying cardiac electrical heterogeneity in patients with conversion disorder.Tokatli A, Yiginer O, Degirmencioglu G, Kilicaslan F, Uzun M.Ther Clin Risk Manag. 2015 Jul 20;11:1077-80.

    Kaynak: medicana.com.tr profil sayfası

  17. 17.An Issue Waiting to be Clarified: Effects of the QT Prolonging Drugs on Tp-e Interval. Yiginer O, Dogan M, Erdal E.Arq Bras Cardiol. 2015 Jun;104(6):507

    Kaynak: medicana.com.tr profil sayfası

  18. 18.A step forward parameter for the effects of transcatheter aortic valve implantation: transmural dispersion of repolarization.Tezcan M, Yiğiner Ö, Doğan M, Değirmencioğlu G.J Geriatr Cardiol. 2015 May;12(3):326-8.

    Kaynak: medicana.com.tr profil sayfası

  19. 19.Effect of cardiac rehabilitation on ventricular repolarization in patients with type 2 diabetes and coronary heart disease: Non-invasive quantification via transmural dispersion of repolarization.Tokatli A, Yiginer O, Kilicaslan F, Uzun M.Heart Lung. 2015 Sep-Oct;44(5):459-60.

    Kaynak: medicana.com.tr profil sayfası

  20. 20.Efficiency of quantification of cardiac electrical heterogeneity: via QT dispersion, transmural dispersion, or both.Tokatli A, Yiginer O, Haholu A, Uzun M. Biol Sport. 2015 Jun;32(2):175-6. doi: 10.5604/20831862.1145079. Epub 2015 Mar 17.

    Kaynak: medicana.com.tr profil sayfası

  21. 21.The combination of hydralazine and isosorbide dinitrate: the only antioxidant treatment recommended in the guidelines.Yiginer O, Tokatli A, Haholu A, Ozmen N. Eur Rev Med Pharmacol Sci. 2015 May;19(10):1745-6

    Kaynak: medicana.com.tr profil sayfası

  22. 22.Twin hearts: identical anomalous coronary origin, individual vasculature Tezcan M, Yiğiner Ö, Cebeci BS.Anatol J Cardiol. 2015 Apr 1;15(4):

    Kaynak: medicana.com.tr profil sayfası

  23. 23.Frequently occurring Torsades de pointes attacks in an old patient on solifenacin therapy and management strategy.Özmen N, Yiğiner Ö, Ün H, Bıçakçı B.Anatol J Cardiol. 2015 Apr;15(4):342-3.

    Kaynak: medicana.com.tr profil sayfası

  24. 24.Dulce RA, Yiginer O, Gonzalez DR, Goss G, Feng N, Zheng M, Hare JM. Hydralazine and Organic Nitrates Restore Impaired Excitation-Contraction Coupling by Reducing Calcium Leak Associated with Nitroso-Redox Imbalance. J Biol Chem. 2013 Jan 15. [Epub ahead of print)

    Kaynak: medicana.com.tr profil sayfası

  25. 25.Melatonin protects against ischemic heart failure in rats. Sehirli AO, Koyun D, Tetik S, Ozsavcı D, Yiğiner O, Cetinel S, Tok OE, Kaya Z, Akkiprik M, Kılıç E, Sener G. J Pineal Res. 2013 Mar 15

    Kaynak: medicana.com.tr profil sayfası

  26. 26.Yalcin M, Kardesoglu E, Aparci M, Isilak Z, Uz O, Yiginer O, Ozmen N, Cingozbay BY, Uzun M, Cebeci BS Cardiovascular risk scores for coronary atherosclerosis Acta Cardiol. 2012 Oct;67(5):557-63

    Kaynak: medicana.com.tr profil sayfası

  27. 27.Yiginer O, Ozcelik F, Inanc T, Aparci M, Ozmen N, Cingozbay BY, Kardesoglu E, Suleymanoglu S, Sener G, Cebeci BS. Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome. Clin Res Cardiol. 2008 May;97(5):334-40.

    Kaynak: medicana.com.tr profil sayfası

  28. 28.Yiginer O, Keser N, Ozmen N, Tokatli A, Kardesoglu E, Isilak Z, Uz O, Uzun M. Classic mitral valve prolapse causes enlargement in left ventricle even in the absence of significant mitral regurgitation. Echocardiography. 2012 Feb;29(2):123-9.

    Kaynak: medicana.com.tr profil sayfası

  29. 29.Yiginer O, Bas S, Pocan S, Yildiz A, Alibek S. Incidental findings of cardiac MSCT: who might benefit from scanning the entire thorax on Ca score imaging? Int J Cardiol. 2010 Apr 15;140(2):239-41.

    Kaynak: medicana.com.tr profil sayfası

  30. 30.Yiginer O, Uzun M, Yilmaz Cingozbay B, Kardesoglu E, Atalay M, Isilak Z, Uz O, Keser N, Sitki Cebeci B. A simplified proximal isovelocity surface area method for mitral valve area calculation in mitral stenosis: not requiring angle correction and calculator. Med Glas Ljek komore Zenicko-doboj kantona. 2011 Aug;8(2):197-202.

    Kaynak: medicana.com.tr profil sayfası

  31. 31.Yiginer O, Kilicaslan F, Aparci M, Isilak Z, Uz O, Bayrak F, Eroglu E, Uzun M, Kardesoglu E, Kirilmaz A, Cebeci BS. Advanced Age, Female Gender and Delay in Pacemaker Implantation May Cause TdP in Patients With Complete Atrioventricular Block. Indian Pacing Electrophysiol J. 2010 Oct 31;10(10):454-63.

    Kaynak: medicana.com.tr profil sayfası

  32. 32.Yiğiner O, Ozmen N, Ozçelik F, Inanç T, Kardeşoğlu E, Uz O, Işılak Z, Aparcı M, Sahin I, Arslan E, Cebeci BS. [Adherence to statin therapy and LDL cholesterol goal attainment in type 2 diabetics and secondary prevention patients: the role of education and knowledge].Turk Kardiyol Dern Ars. 2010 Dec;38(8):544-50.

    Kaynak: medicana.com.tr profil sayfası

  33. 33.Yiginer O, Bas S, Feray H. Demonstration of coronary-to-pulmonary fistula with MDCT and conventional angiography. Int J Cardiol. 2009 May 29;134(3):e126-8.

    Kaynak: medicana.com.tr profil sayfası

  34. 34.Yiğiner O, Kardeşoğlu E, Uz O, Ozmen N, Cebeci BS. [Cardiac regenerative therapy: which type of cell will breast the tape?/Autologous stem cell therapy with surgical myocardial revascularization-The Rostock University experience].Anadolu Kardiyol Derg. 2011 May;11(3):277;

    Kaynak: medicana.com.tr profil sayfası

  35. 35.Yiginer O, Uz O, Kardesoglu E, Tokatli A, Sildiroglu HO, Ozmen N. Noncompaction of the myocardium coexistent with vertebral hemangiomas. Tex Heart Inst J. 2011;38(2):212-3.

    Kaynak: medicana.com.tr profil sayfası

  36. 36.Yiğiner O, Kılıçaslan F, Tokatlı A, Işılak Z. [Concealed Brugada syndrome that became apparent incidentally during atrial fibrillation therapy]. Turk Kardiyol Dern Ars. 2011

    Kaynak: medicana.com.tr profil sayfası

  37. 37.Yiginer O, Kardesoglu E, Ozmen N, Aparci M, Cebeci BS. Complete resolution of very late stent thrombosis with systemic thrombolysis. J Cardiovasc Med (Hagerstown). 2011 Oct;12(10):765-7.

    Kaynak: medicana.com.tr profil sayfası

  38. 38.Yiğiner O, Cingözbay BY, Uz O, Cebeci BS. An overlooked diagnosis on transthoracic echocardiography: apical hypertrophic cardiomyopathy. Turk Kardiyol Dern Ars. 2009 Dec;37(8):569-71.

    Kaynak: medicana.com.tr profil sayfası

  39. 39.Yiğiner O, Ozçelik F, Aparci M, Işilak Z, Uz O. The beneficial effects of allopurinol in cardiology practice: decrease in uric acid and vascular oxidative stress/ the effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pilot study. Anadolu Kardiyol Derg. 2010 Jun;10(3):294-5; author reply 295-6.

    Kaynak: medicana.com.tr profil sayfası

  40. 40.Kilicaslan F, Tokatli A, Ozdag F, Uzun M, Uz O, Isilak Z, Yiginer O, Yalcin M, Guney MS, Cebeci BS.Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio are prolonged in patients with moderate and severe obstructive sleep apnea. Pacing Clin Electrophysiol. 2012 Aug;35(8):966-72.

    Kaynak: medicana.com.tr profil sayfası

  41. 41.Yıldırım M, Yiginer O, Uzun M, Yilmaz Cingozbay B, Sag C, Kutsi Kabul H, Uz O, Isilak Z, Kardesoglu E, Sitki Cebeci B.Aortic flow propagation velocity as an early predictor of high coronary risk in hypertensive patients.Med Glas Ljek komore Zenicko-doboj kantona. 2012 Feb;9(1):42-8.

    Kaynak: medicana.com.tr profil sayfası

  42. 42.Işılak Z, Cay S, Yiğiner O, Uzun M. Biventricular noncompaction and mitral cleft.Anadolu Kardiyol Derg. 2012 Jun;12(4):361-2. doi: 10.5152/akd.2012.102.

    Kaynak: medicana.com.tr profil sayfası

  43. 43.Isilak Z, Kardesoglu E, Aparci M, Uz O, Yalcin M, Yiginer O, Cingozbay BY, Uzun M. Comparison of clinical risk assessment systems in predicting three-vessel coronary artery disease and angiographic culprit lesion in patients with non-ST segment elevated myocardial infarction/unstable angina pectoris. Kardiol Pol. 2012;70(3):242-50.

    Kaynak: medicana.com.tr profil sayfası

  44. 44.Ozcelik F, Arslan E, Serdar MA, Yiginer O, Oztosun M, Kayadibi H, Kurt I. A useful method for the detection of ethylenediaminetetraacetic Acid- and cold agglutinin-dependent pseudothrombocytopenia. Am J Med Sci. 2012 Nov;344(5):357-62.

    Kaynak: medicana.com.tr profil sayfası

  45. 45.Ozmen N, Uz O, Cingözbay BY, Yiğiner O. [Successful percutaneous retrieval of a broken intravascular ultrasound catheter tip from the renal artery]. Turk Kardiyol Dern Ars. 2011 Sep;39(6):505-7.

    Kaynak: medicana.com.tr profil sayfası

  46. 46.Uz O, Kardesoglu E, Tas D, Acar G, Isilak Z, Yiginer O, Aparci M, Cingozbay BY, Cebeci BS.CA-125 level is associated with right ventricular echocardiographic parameters in patients with COPD. South Med J. 2011 Sep;104(9):624-8.

    Kaynak: medicana.com.tr profil sayfası

  47. 47.Kardesoglu E, Isilak Z, Uz O, Yiginer O.An independent prognostic factor for heart failure: sympathetic hyperactivity.Chin Med J (Engl). 2011 Apr;124(7):1118.

    Kaynak: medicana.com.tr profil sayfası

  48. 48.Uz O, Kardesoglu E, Uzun M, Isilak Z, Yiginer O, Aparcı M, Ozmen N, Cebeci BS. Effect of position changes on myocardial velocity in healthy subjects evaluated by tissue Doppler echocardiography.Echocardiography. 2011 May;28(5):516-9.

    Kaynak: medicana.com.tr profil sayfası

  49. 49.Kardesoglu E, Isilak Z, Uz O, Yiginer O. Ischemic conditioning: a current concept in reducing reperfusion injury. Chin Med J (Engl). 2011 Feb;124(3):480.

    Kaynak: medicana.com.tr profil sayfası

  50. 50.Ozmen N, Guney MS, Togrul E, Yiginer O, Aparci M, Kardesoglu E, Cingozbay Y, Saracoglu M, Cebeci BS. Elastic characteristics of aorta in patients with epilepsy. Med Glas Ljek komore Zenicko-doboj kantona. 2011 Feb;8(1):15-8.

    Kaynak: medicana.com.tr profil sayfası